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Abstract
Background Despite the widespread use of noninvasive
testing prior to invasive coronary diagnostic the diagnostic
yield of elective coronary angiography has been reported
low in subjects with suspected obstructive CAD.
Objective To determine the predictive value of non-
coronary atherosclerosis (NCA) in subjects with suspected
stable coronary artery disease (CAD) intended to invasive
coronary angiography.
Methods Ultrasound-based assessment of carotid artery
plaque (CAP), carotid intima-media thickness (CIMT) and
ankle-brachial index (ABI) was performed in 2216 subjects
with suspected CAD prior to coronary angiography.
Logistic regression and c-statistics were used to analyze the
diagnostic value of NCA for the presence of obstructive
CAD and the intention to revascularization.
Results Percentage of positive results of elective coro-
nary angiography was low but comparable to other studies
(41 % obstructive CAD). We identified 1323 subjects
(60 %) with NCA, most of them were characterized by
CAP (93 %). CAP independently predicted obstructive
CAD in addition to traditional risk factors and clinical
factors while CIMT and ABI failed to improve the pre-
diction. The presence of NCA and typical angina were the
strongest predictors for obstructive CAD (OR 4.0 and 2.4,
respectively). A large subgroup of patients (n = 703,
32 %) with atypical clinical presentation and lack of NCA
revealed a low indication for revascularization \15 %
indicating a large proportion of subjects with non-ob-
structive CAD in this subgroup.
Conclusion The evaluation of noncoronary atherosclero-
sis has the potential to impact clinical decision making and
to direct subsequent diagnostic procedures in subjects with
suspected coronary artery disease.
Clinical trial registration NCT00497887.
Keywords Coronary artery disease  Noncoronary
atherosclerosis, carotid artery plaque  Intima-media
thickness  Ankle-brachial index
Background
Noninvasive testing is recommended in patients with sus-
pected stable ischemic heart disease (SIHD) prior to
invasive coronary angiography to identify subjects at risk
[1, 2]. Functional or stress testing to detect inducible
ischemia has been the gold standard and is the most
common noninvasive test used to diagnose SIHD.
Electronic supplementary material The online version of this
article (doi:10.1007/s00392-015-0900-x) contains supplementary
material, which is available to authorized users.
& Frank Beutner
beutner.le@googlemail.com
1 Department of Cardiology, Heart Center University Leipzig,
Stru¨mpellstr. 39, 04289 Leipzig, Germany
2 LIFE-Leipzig Research Center for Civilization Diseases,
University Leipzig, Leipzig, Germany
3 Institute of Medical Informatics, Statistic and Epidemiology,
University Leipzig, Leipzig, Germany
4 Institute of Laboratory Medicine, Ludwig-Maximilian
University, Munich, Germany
5 Department of Medicine III, University Hospital Halle
(Saale), Halle/Saale, Germany
6 Institute of Laboratory Medicine, Clinical Chemistry and
Molecular Diagnostics, University Hospital Leipzig, Leipzig,
Germany
123
Clin Res Cardiol (2016) 105:172–181
DOI 10.1007/s00392-015-0900-x
However, its high predictive value shown in myriad diag-
nostic studies is not translated into clinical reality. In less
than half of the patients intended to elective coronary
angiography significant obstructive CAD is confirmed [3].
The diagnostic yield of current noninvasive testing before
heart catheterization is low and patients with a positive
result on a noninvasive test exhibit only a slightly higher
likelihood to have obstructive CAD than those who did not
undergo any testing [3].
The generalized nature of atherosclerosis is expressed in
the concomitant occurrence of CAD with noncoronary
atherosclerotic diseases [4]. Noninvasive imaging tests
aiming at detecting noncoronary atherosclerotic disease
might be helpful in addition to the clinical presentation and
functional/stress testing to direct diagnostic strategies in
subjects with unknown but suspected CAD.
In the last two decades, measures of noncoronary
atherosclerosis [NCA, e.g., carotid artery plaque, carotid
intima-media thickness (CIMT), ankle-brachial index
(ABI)] became surrogate marker broadly accepted for the
prediction of incident cardiovascular events [5–7]. Recent
studies showed that especially ultrasound-based carotid
artery plaque assessment is also predictive for prevalent
CAD [8–17]. The appropriate use of CIMT and ABI testing
and its impact as measures for risk assessment have been
defined for several scenarios [18, 19]. The clinical impact
of the ultrasound-based assessment of noncoronary
atherosclerosis in subjects with suspected CAD considered
for invasive cardiac catheterization has not been defined so
far.
In the present study, we investigate the association of
carotid artery ultrasound measures (CIMT, carotid plaque),
the ankle-brachial index (ABI) and the patients history of
peripheral or cerebrovascular disease with obstructive
CAD as confirmed by coronary angiography in subjects




The Leipzig Heart Study is designed as an observational
study to evaluate biomarkers and their ability to assess the
presence and severity of CAD in subjects with suspected
CAD. A detailed description of study design and baseline
characteristics has been published elsewhere [20]. The
study meets the ethical standards of the Declaration of
Helsinki, and written informed consent was obtained from
all participants.
The present study included 2552 subjects with suspected
stable CAD. Patients were admitted to the Leipzig
University Heart Center (2006–2011) for invasive coronary
angiography due to the presence of clinical symptoms (e.g.,
chest pain, shortness of breath) and positive noninvasive
testing (e.g., cardiopulmonary exercise test, echocardio-
graphic, nuclear or magnetic resonance imaging). Patients
with known CAD and any previous coronary revascular-
ization in form of percutaneous coronary intervention
(PCI) or coronary artery bypass graft (CABG) were
excluded in order to recruit only those with first onset of
symptoms and untreated coronary arteries. We excluded
195 cases in which documentation of their medical history
was incomplete and 141 cases in which ultrasound was not
available or with insufficient quality. Finally, 2216 subjects
were included into the analyses.
Risk factors and clinical presentation
Risk factors and clinical presentation were obtained from a
standardized interview, a standardized biometric assess-
ment and laboratory analyses as published before [20].
Chest pain was inquired using the WHO Rose Angina
Questionnaire [21]. The classification of chest pain in
nonanginal chest pain, atypical angina and typical angina
was performed according to the guidelines [1]. High-sen-
sitive C-reactive protein (hs-CRP) and n-terminal pro brain
natriuretic peptide (nt-proBNP) have been shown associ-
ated with cardiovascular phenotypes and coronary events
in stable subjects and were integrated in the analyses [22–
25].
Evaluation of noncoronary atherosclerosis
History of peripheral vascular disease (PVD)
Information about interventions due to lower extremity
artery disease (LEAD) and cerebrovascular disease (CVD)
were obtained from the interview.
Carotid artery plaque
The ultrasound procedure of carotid arteries has been
described in detail before [20] (brief description in sup-
plemental material). Carotid artery plaque was defined as
recommended by the American Society of Echocardiog-
raphy Intima-Media Thickness Task Force [26]: echogenic
thickening of intimal reflection that extends into the arterial
lumen at least 0.5 mm or 50 % of the surrounding CCA-
IMT value or an intimal ? medial thickness of[1.5 mm.
Plaque presence was documented as ‘present’ or ‘absent’
for the common part and bulb of the right and left carotid
artery, respectively. A simple plaque score (PS) was cal-
culated by counting segmental plaque presence of the
common carotid artery and bulb. As the extracranial length
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of internal carotid artery and the quality of its imaging is
variable, we restricted plaque score determination to the
common part and the bulb resulting in values of 0–4. Intra-
and inter-reader reliability of carotid artery plaque assess-
ment were tested in scans of 60 subsequent subjects being
read by 4 sonographers, each blinded from the other’s
findings. Krippendorff’s alpha was 0.90 for intra-reader
reliability and 0.65 for interreader reliability (further data
in Supplemental Table 1).
Carotid intima-media thickness (CIMT)
The mean and maximum of the combined thickness of the
intimal and medial layer of the far wall of the CCA were
measured with a semiautomated border detection program
(EchoPAC Dimension 06, GE Medical Systems, Munich,
Germany). The detecting area of CIMT was defined as the
distal 1 cm (about 250 single measure points) of the
common carotid arteries, proximal to the origin of the bulb
(Supplemental Fig. 2a–c). Measurements of the left and
right sides were averaged to obtain the CIMTmean, the
higher value of the left and right maximum CIMT was used
to obtain CIMTmax. Intra- and inter-reader reliability of
CIMT were tested in scans of 60 subsequent subjects being
read by 4 sonographers, each blinded from the other’s
findings. Concordance correlation coefficients (CCC) for
intra-reader reliability were 0.95 (CIMTmean) and 0.91
(CIMTmax), CCC for interreader reliability were 0.90
(CIMTmean) and 0.87 (CIMTmax), further data in the
Supplemental Table 1.
Ankle-brachial index (ABI)
Systolic blood pressures of the right arm and both ankles
are measured twice by gold standard method Doppler
ultrasound using sphygmomanometer cuffs and a handheld
Doppler probe (Huntleigh Mini-Dopplex, Kempen, Ger-
many) [27]. ABI was calculated by dividing the averaged
systolic blood pressure at the posterior tibial artery by the
averaged systolic blood pressure in the arm. The lower ABI
of the right and left side was used for analyses. Subjects
were categorized in subgroups of normal (C1.1), low-
normal (1.00–1.09), borderline (0.9–0.99), pathological
(0.5–0.89) and critical (\0.5) ABI.
Coronary angiography
Coronary angiography was performed following the stan-
dards of our institution [20]. Patients were classified in
subsets with (1) normal angiogram or nonobstructive CAD
with luminal reduction \50 % and (2) obstructive CAD
with at least one stenosis C50 % in a major coronary
vessel. Additionally, subjects were classified with respect
to subsequently induced therapeutic interventions namely
conservative therapy or intention to coronary revascular-
ization [percutaneous coronary intervention (PCI) or
coronary artery bypass grafting (CABG)].
Statistics
Categorical data are presented as numbers or percentages
and were compared using v2 or Fisher’s exact test, as
appropriate. For continuous variables, we present arith-
metic mean ± standard deviation for normally distributed
variables and median ± standard deviation for non-nor-
mally distributed variables. Continuous variables were
compared using Student’s t test and Mann–Whitney U test,
as appropriate. Odds ratios (OR) of CIMTmean, CIMTmax
(per 0.1 mm), carotid artery plaque (per point of plaque
score), ABI and clinical factors were obtained from logistic
regression analyses, adjusted for traditional risk factors
(age, gender, diabetes, tobacco use, hypertension, dyslipi-
demia). Stepwise forward logistic regression (Wald Chi
square) was performed to identify major predictors.
Receiver operating characteristic (ROC) was performed
for:
1. Traditional risk factors (TRF),
2. TRF ? clinical factors [clinical presentation (angina,
NYHA), history of PVD, reduced left-ventricular
ejection fraction \50 %, hsCRP, ntproBNP] and the
incremental impact of carotid ultrasound measures to
2):
3. ?CIMTmean,
4. ?Carotid artery plaque,
5. ?ABI.
Sensitivity and specificity were calculated for a positive
carotid plaque test (C1 plaque in CCA or bulb). P values
\0.05 were considered statistically significant. IBM SPSS
Statistics 20 was used for statistical analyses of models.
The statistical software package ‘‘R’’ (www.r-project.org’’)
was used to perform concordance analyses.
Results
Baseline characteristics of the participants
Demographic and clinical characteristics of the study
subjects are summarized in Table 1. The median age was
64 years (interquartile range 54–70 years); 35.3 % were
female; 31.7 % were diabetics. Chest pain was the reason
for cardiac diagnostic assessment in 64.2 % of participants.
25.0 % presented with typical angina and 39.2 % were
classified as atypical angina or non-cardiac chest pain. The
remaining subjects presented with other atypical clinical
174 Clin Res Cardiol (2016) 105:172–181
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presentation but a positive result in former noninvasive
testing. The distribution of the clinical presentation in our
German cohort intended for invasive coronary diagnostic is
comparable with the American NCDR CathPCI Registry.
In this large-scale study, 33 % subjects were graded as
stable angina and the remaining subjects with atypical or
asymptomatic presentation [3].
Prevalence of noncoronary atherosclerosis
Findings of noncoronary atherosclerosis are summarized in
Table 2. History of peripheral artery disease was reported
in 4.5 % of the subjects. Carotid arterial lesions were
present in 55.7 % (men 61.8 %, women 44.1 %). Carotid
artery plaque more often occurs in the bulb (54.0 %) than
in the common part of the carotid artery (24.0 %,
P\ 0.001). The majority of subjects had a normal and
low-normal ABI (51.4 and 29.7 %, respectively). Signifi-
cant ABI values\0.9 were found in 254 subjects (11.5 %).
Cumulative noncoronary atherosclerotic disease was
identified in 1323 subjects (59.7 %). Thereof, carotid artery
plaque was present in the majority of subjects (93.3 %), the
other PVD characteristics were less present (PVD in his-
tory 7.5 %, CIMTmax[ 1.5 mm 2.3 %, ABI\ 0.9 19.2 %
of subjects with NCA).
Prevalence of coronary artery disease
Angiographically significant CAD was present in 41.2 %
of the subjects (48.7 % of men, 27.5 % of women)
resulting in assignment to PCI or CABG in 37.5 % of
males and 20.8 % of females. The remaining subjects were
free of angiographically visible CAD or showed wall
irregularities\50 % luminal reduction. These findings of
diagnostic angiography show high accordance with the
American NCDR CathPCI Registry (41.0 % with
obstructive CAD) [3].
Predictors of obstructive CAD
Known conventional risk factors higher age, male sex,
diabetes, dyslipidemia and tobacco use were independently
Table 1 Baseline characteristics of the study participants
Characteristic Total (n = 2216) Obstructive CAD (n = 913) No obstructive CAD (n = 1303) P value
Age (years) 64 ± 11 66 ± 11 62 ± 11 \0.001
Female sex (%) 35.3 23.5 43.5 \0.001
Body mass index (kg/m2) 29.2 ± 5.0 29.0 ± 4.6 29.4 ± 5.2 0.190
Waist-hip ratio 0.98 ± 0.08 1.01 ± 0.07 0.96 ± 0.09 \0.001
Diabetes (%) 31.7 35.9 28.7 \0.001
Hypertension (%) 83.3 84.1 82.7 0.387
Dyslipidemia (%) 47.8 58.3 41.7 \0.001
Tobacco use
Former (%) 38.3 42.4 35.5 \0.001
Current (%) 17.0 20.4 14.7
Family history (%) 32.4 33.1 31.8 0.553
Ejection fraction\50 % 15.3 19.5 12.3 \0.001
hsCRP (mg/l) 2.2 ± 9.7 2.6 ± 11.8 2.0 ± 7.7 \0.001
Nt-proBNP (ng/l) 149 ± 1255 226 ± 1480 120 ± 1056 \0.001
Medication
ASA (%) 50.6 59.5 44.0 \0.001
Beta blocker (%) 57.9 58.4 57.6 0.783
RAAS antagonist (%) 67.6 69.3 66.3 0.293
Calcium antagonist (%) 24.0 24.5 23.6 0.717
Diuretic (%) 38.1 38.4 37.8 0.849
Statin (%) 36.6 42.7 32.2 \0.001
Clinical presentation
NCP/AA/TA (%) 15.7/23.5/25.0 11.0/22.0/35.0 19.1/24.6/18.0 \0.001
NYHA II/III (%) 41.4/11.0 40.4/9.4 42.1/12.3 0.009
P value refers to the comparison of the obstructive CAD/no obstructive CAD groups
hsCRP high-sensitive C-reactive protein, NCP nonanginal chest pain, AA atypical angina, TA typical angina. P value refers to the comparison of
the obstructive CAD/no obstructive CAD groups
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associated with obstructive coronary artery disease and
revascularization. An echocardiographic reduction of the
left-ventricular ejection fraction, higher levels of high-
sensitive C-reactive protein and nt-pro brain natriuretic
peptide were also independently associated with
obstructive coronary artery disease (Table 3) and revas-
cularization (Supplemental Table 2).
The clinical presentation of typical angina (OR 3.1) as well
as atypical angina (OR 1.4) was associated with obstructive
CAD and revascularization. In contrast, the classification
Table 2 Prevalence of
noncoronary atherosclerosis
Characteristic Total Obstructive CAD No obstructive CAD P value
History of atherosclerotic disease
LEAD (%) 3.4 5.9 1.7 \0.001
CVD (%) 1.3 2.0 0.8 0.022
PVD (%) 4.5 7.3 2.5 \0.001
Presence of carotid arterial lesions
Carotid plaque (%) 55.7 73.9 43.0 \0.001
CPS 1/2/3/4 (%) 16.8/19.9/10.2/8.9 17.9/25.1/15.7/15.2 16.0/16.2/6.3/4.5 \0.001
CIMTmean (mm) 0.78 ± 0.15 0.82 ± 0.15 0.76 ± 0.14 \0.001
CIMTmax (mm) 0.94 ± 0.20 0.99 ± 0.21 0.92 ± 0.19 \0.001
Presence of lower extremity arterial disease
ABI C 1.1 51.4 43.8 56.7 \0.001
1.0–1.09 29.7 27.5 31.3
0.9–0.99 7.4 9.9 5.7
0.5–0.89 9.3 14.5 5.6
\0.5 2.2 4.4 0.7
Cumulative NCA (%) 59.7 78.1 46.8 \0.001
P value refers to the comparison of the obstructive CAD/no obstructive CAD groups
LEAD lower extremity artery disease, CVD cerebrovascular disease, PVD peripheral vascular disease, CPS
carotid plaque score, CIMT carotid intima-media thickness, ABI ankle-brachial index, NCA noncoronary
atherosclerosis
Table 3 The value of traditional risk factors and clinical characteristics for predicting obstructive CAD
Variable Unadj. odds ratio (95 % CI) P value Adj. odds ratio (95 % CI) P Value
Traditional risk factors
Age, per 5 years increase 1.13 (1.08–1.17) \0.001
Male sex 2.50 (2.07–3.02) \0.001
Diabetes 1.39 (1.16–1.66) \0.001
Dyslipidemia 1.95 (1.64–2.31) \0.001
Hypertension 1.11 (0.88–1.39) 0.389
Former tobacco use 1.60 (1.32–1.93) \0.001
Current tobacco use 1.86 (1.46–2.37) \0.001
Additional clinical characteristics
Family history of CAD 1.06 (0.87–1.30) 0.553 1.19 (0.96–1.48) 0.118
LV-EF\50 % 1.73 (1.37–2.19) \0.001 1.31 (1.02–1.69) 0.034
hsCRP, per 5 mg/l 1.11 (1.06–1.17) \0.001 1.08 (1.03–1.14) 0.004
Nt-proBNP, per 500 ng/l 1.11 (1.06–1.16) \0.001 1.06 (1.01–1.10) 0.009
Clinical presentation
Nonanginal chest pain 0.69 (0.52–0.90) 0.007 0.85 (0.64–1.14) 0.290
Atypical angina 1.07 (0.86–1.35) 0.543 1.38 (1.08–1.76) 0.011
Typical angina 2.33 (1.86–2.91) \0.001 3.09 (2.42–3.95) \0.001
Dyspnea NYHA II 0.83 (0.68–0.99) 0.042 0.90 (0.73–1.09) 0.274
NYHA III 0.67 (0.50–0.90) 0.008 0.64 (0.46–0.88) \0.001
176 Clin Res Cardiol (2016) 105:172–181
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‘nonanginal chest pain’ and shortness of breath neither did
predict obstructive CAD nor revascularization.
All noncoronary atherosclerotic disease characteristics
were independently (i.e., after adjustment for traditional
risk factors) associated with obstructive coronary artery
disease (Fig. 1; Table 4) and revascularization (Supple-
mental Table 2). The presence of carotid artery plaque
predicted obstructive CAD with OR 2.8. Multisegmental
affection of the carotid arterial system linearly increased
the predictive value to OR 4.9. Mean and maximum CIMT
were independently associated with CAD (per 0.1 mm
increase OR 1.13). ABI values\1.0 predicted obstructive
CAD with OR 2.5. In summary, any noncoronary
atherosclerosis predicted obstructive CAD and revascular-
ization with OR 3.0.
Diagnostic benefit of NCA testing
To investigate which method of NCA testing is best suited
to improve diagnostic of CAD and revascularization, we
analyzed C-statistics of carotid plaque, ABI and CIMT.
C-statistic showed that carotid artery plaque assessment
best improved the prediction of obstructive CAD and the
intention for revascularization while ABI was inferior and
CIMT failed to give independent impact to a model
including TRF and clinical factors (CF, including angina,
NYHA, history of PVD, reduced left-ventricular ejection
fraction\50 %, hsCRP, ntproBNP), Fig. 2. The area under
the curve (AUC) to predict obstructive CAD improved
from 0.69 (TRF) and 0.73 (TRF ? CF) to 0.77
(TRF ? CF ? carotid plaque), P\ 0.001. The AUC to
predict the need for revascularization improved from 0.67
(TRF) and 0.72 (TRF ? CF) to 0.75 (TRF ? CF ? carotid
plaque), P\ 0.001.
Calculating the optimal cut-off for the number of carotid
artery segments diseased to predict obstructive CAD,
Youden’s index reached its maximum at one segment
diseased. The strength of NCA testing is the high negative
predictive value especially in subjects with atypical clinical
presentation reaching negative predictive values of 81 %
for obstructive CAD and 87 % for revascularization (de-
tailed data of specificity, sensitivity, positive and negative
predictive value in Supplemental Table 3).
Typical angina and noncoronary atherosclerosis—
the major signs of stable obstructive CAD
Stepwise logistic regression identified two major predictors
for stable obstructive CAD: the presence of noncoronary
atherosclerosis (OR 4.0, CI 3.3–4.8) and typical angina
(OR 2.4, CI 1.9–3.0). Both were also the strongest pre-
dictors for revascularization: NCA OR 3.6 (CI 2.9–4.5) and
typical angina OR 2.7 (CI 2.1–3.5). The impact of the
assessment of NCA to predict CAD and revascularization
was evident independently of age and gender (Supple-
mental Table 4). The strong predictive value of NCA was
demonstrated independently of the clinical presentation
(Fig. 3). However, the relevance of noncoronary
atherosclerosis is pivotal in subjects with atypical clinical
presentation. While subjects with typical angina already
have a higher pretest probability for obstructive CAD and
revascularization, subjects with atypical clinical presenta-
tion demonstrated a lower pretest probability with ques-
tionable necessity for invasive coronary angiography.
Under this condition, the detection of noncoronary
atherosclerosis significantly increased the pretest proba-
bility to higher than 40 %, while subjects without detect-
able noncoronary atherosclerosis were unlikely to have
obstructive CAD (\20 %) and were even more unlikely to
get coronary revascularization (\15 %, Fig. 3). Atypical
clinical presentation and lacking detection of NCA applies
to a large group of patients in our cohort (n = 703, 32 %).
Discussion
The objective of our study was to evaluate the predictive
value of noncoronary atherosclerosis assessment for iden-
tifying coronary artery disease and the need for
Fig. 1 Odds ratios and error bars for measures of noncoronary
atherosclerosis and features of clinical presentation predicting
obstructive CAD in subjects with suspected CAD
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revascularization in a cohort of patients with clinical
symptoms indicating first-time elective invasive coronary
angiography. Our major results are:
1. A simple ultrasound-based screening for noncoronary
atherosclerosis improved the pretest probability of
obstructive CAD and the intention to revascularization
prior to invasive coronary angiography. Its strength is
the high negative predictive value in subjects with
atypical clinical presentation identifying a large group
of subjects with low probability of obstructive CAD.
2. Especially ultrasound-based carotid artery plaque
assessment was identified as a useful measure of
noncoronary atherosclerosis. The presence of carotid
artery plaque and its extent were independently
associated with the first-time diagnosis of stable
obstructive CAD after adjustment for traditional
Fig. 2 Bars indicate the area under the ROC curve of various models
to predict obstructive CAD (a) and coronary revascularization (b).
The simplest model (TRF) includes the traditional risk factors (age,
gender, diabetes status, hypertension, tobacco use, serum LDL-
cholesterol, HDL-cholesterol adjusted for lipid lowering medication).
In model 2 further clinical factors (angina, NYHA, history of PVD,
left-ventricular ejection fraction) and biomarker (hsCRP, ntproBNP)
were included. Finally, vascular ultrasound measures (CIMT, carotid
artery plaque, ABI) were added to model 2, respectively
Fig. 3 Percentage of subjects with obstructive CAD (a) and coronary
revascularization (b) depending on the absence (lightly colored) and
presence (dark colored) of noncoronary atherosclerotic disease
(NCA) and the clinical presentation (x-axis, subset of nonanginal
chest pain includes subjects without chest pain)
Table 4 The value of
noncoronary atherosclerosis for
predicting obstructive CAD
Variable Unadj. odds ratio (95 % CI) P value Adj. odds ratio (95 % CI) P value
History of PVD 3.14 (2.05–4.83) \0.001 2.17 (1.38–3.41) 0.001
Carotid artery plaque 3.76 (3.13–4.52) \0.001 2.75 (2.26–3.35) \0.001
1 Segment 2.43 (1.89–3.13) \0.001 2.04 (1.57–2.64) \0.001
2 Segments 3.39 (2.67–4.30) \0.001 2.54 (1.98–3.27) \0.001
3 Segments 5.48 (4.03–7.46) \0.001 3.81 (2.75–5.27) \0.001
4 Segments 7.48 (5.33–10.5) \0.001 4.87 (3.40–6.98) \0.001
CIMTmean per 0.1 mm 1.31 (1.23–1.40) \0.001 1.13 (1.06–1.22) 0.001
CIMTmax per 0.1 mm 1.28 (1.21–1.35) \0.001 1.13 (1.06–1.20) \0.001
ABI 1.0–1.09 1.14 (0.93–1.39) 0.207 1.19 (0.96–1.47) 0.111
0.9–0.99 2.25 (1.61–3.13) \0.001 2.20 (1.54–3.14) \0.001
0.5–0.89 3.34 (2.45–4.56) \0.001 2.71 (1.93–3.80) \0.001
\0.5 8.21 (3.94–17.1) \0.001 5.80 (2.71–12.4) \0.001
ABI\1.0 2.96 (2.37–3.69) \0.001 2.48 (1.95–3.16) \0.001
NCA 4.05 (3.35–4.90) \0.001 3.02 (2.46–3.71) \0.001
178 Clin Res Cardiol (2016) 105:172–181
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cardiovascular risk factors and further CAD-associated
factors such as clinical presentation, known noncoro-
nary vascular disease, reduced left-ventricular ejection
fraction and additional biochemical markers.
3. CIMT and ABI also independently predicted obstruc-
tive CAD after adjustment for traditional risk factors
but CIMT and ABI failed to add significant diagnostic
value to a model including of established risk factors
and carotid artery plaque.
The observation that carotid artery plaque is able to
predict prevalent CAD has been reported in some small
angiographic studies [11–17]. Our much larger study
additionally investigated the relationship between carotid
ultrasound findings and the intention for coronary revas-
cularization. Furthermore, our analyses were interpreted in
the context of important clinical factors including the
clinical presentation, cardiac function and biochemical
biomarkers which were disregarded in most of the previous
studies.
Although typical angina is the major clinical presenta-
tion of stable CAD, and, as also demonstrated in our study,
one of the strongest predictors of obstructive CAD, only a
quarter to a third of subjects intended for elective coronary
angiography due to suspected obstructive CAD presents
with typical angina. The majority of patients have an
atypical clinical presentation resulting in a high chance of
negative angiographic results. For these patients, the evi-
dence of noncoronary atherosclerosis is the most important
predictor of obstructive CAD. Conversely, in the subset of
subjects with atypical clinical presentation and no detect-
able noncoronary atherosclerosis the probability of
obstructive CAD is low (\20 %) and the rate of coronary
revascularization is even lower (\15 %). Interestingly, this
applies to a relatively large group of patients in our cohort,
about one third of patients. When cardiologists and other
clinicians consider whether a patient with atypical pre-
sentation has significant coronary artery disease, they are
less likely to want to determine whether noncoronary
atherosclerosis disease is present, unless there is a strong
suspicion that the presence of severe disease could deter-
mine the patient’s near future prognosis, before deciding on
carrying out coronary angiography. However, the clinicians
should consider the increased likelihood of CAD in the
type of patients included in this study if there is evidence of
noncoronary atherosclerosis and the non-invasive tests,
particularly for the presence of carotid artery disease, are
positive.
The superiority of carotid artery plaque assessment
compared to CIMT is explained by its carotid-wide
screening area, while CIMT measurement is limited to the
far wall of the common part of the carotid arteries. Indeed,
atherosclerotic disease occurs predominantly downstream
to the region of CIMT measurement namely in the bulb and
the proximal parts of the internal/external branches of the
carotid artery [28]. We did not consider IMT measurements
of other carotid artery regions due to the limited stan-
dardization of the measurements and focused on that rec-
ommended by the Carotid Intima-Media Thickness Task
Force of the American Society of Echocardiography [26].
In line with our results, a recent meta-analysis showed that
carotid artery plaque has a higher diagnostic accuracy
compared with CIMT for the prediction of future CAD
events [9]. Further studies also showed that CIMT added
only little predictive value to conventional risk factors [8,
9, 11]. Today there is strong evidence for the superiority of
carotid artery plaque assessment for the prediction of
incident cardiovascular events, and as here shown also for
prevalent CAD, which evokes increasing debate regarding
the IMT paradigm [29–31].
A limitation of our study is the mono-centric design
which might be biased by local characteristics of allocation
and accomplishment. However, both the distribution of
clinical presentation and angiographic findings is compa-
rable with the representative large-scale American NCDR
CathPCI Registry including hundreds of angiographic
centers [3]. Second, we did not quantify carotid artery
plaque size in this initial study because our results show
that the optimal Youden’s index calculated from our
semiquantitative plaque score was already reached when
only one carotid artery segment was affected. This indi-
cates that the presence of atherosclerosis per se is of
importance. However, the fact that multi-locus carotid
artery plaque further increase the risk of CAD points
towards the usefulness of a more detailed quantification of
carotid atherosclerosis. Several ongoing studies announced
the application of three-dimensional carotid ultrasound to
improve the prediction of the incident cardiovascular risk
[10, 32]. Our carotid ultrasound approach would also allow
3D-morphometric quantification; we aim at improving
CAD risk prediction on the basis o these measures in the
future.
Conclusion
Our study accentuates the diagnostic value of an assess-
ment of noncoronary atherosclerosis, in particular that of
carotid artery plaque, to improve the diagnostic yield of
invasive coronary angiography in subjects with suspected
coronary artery disease. The strength of carotid artery
plaque assessment is pivotal in subjects with atypical
clinical presentation, which represents the majority of
subjects intended to diagnostic coronary angiography. In
view of the low pretest probability within the large group
of subjects with atypical clinical presentation and lack of
Clin Res Cardiol (2016) 105:172–181 179
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noncoronary atherosclerosis, indication for invasive coro-
nary diagnostic should be reassessed carefully. We con-
clude that carotid artery plaque detection has the potential
to assess prognosis and to direct clinical decision making
and subsequent diagnostic procedures in subjects with
suspected coronary artery disease.
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